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Abstract: Older adults are a highly heterogeneous group with variable health and functional 
life courses. Frailty has received increasing scientific attention as a potential explanation of 
the health diversity of older adults. The frailty phenotype and the Frailty Index are the most 
frequently used frailty definitions, but recently new frailty definitions that are more practical 
have been advocated. Prevalence of frailty among the community-dwelling population aged 
65 years and older is ~10% but varies depending on which frailty definitions are used. The 
mean prevalence of frailty gradually increases with age, but the individual’s frailty level 
can be improved. Older adults, especially frail older adults, form the main users of medical 
and social care services. However, current health care systems are not well prepared to deal 
with the chronic and complex medical needs of frail older patients. In this context, frailty 
is potentially a perfect fit as a risk stratification paradigm. The evidence from frailty studies 
has not yet been fully translated into clinical practice and health care policy making. Suc-
cessful implementation would improve quality of care and promote healthy aging as well as 
diminish the impact of aging on health care systems and strengthen their sustainability. At 
present, however, there is no effective treatment for frailty and the most effective interven-
tion is not yet known. Based on currently available evidence, multi-domain intervention 
trials, including exercise component, especially multicomponent exercise, which includes 
resistance training, seem to be promising. The current challenges in frailty research include 
the lack of an international standard definition of frailty, further understanding of interven-
tions to reverse frailty, the best timing for intervention, and education/training of health care 
professionals. The hazards of stigmatization should also be considered. If these concerns 
are properly addressed, widespread application of public health approaches will be possible, 
including screening, identification, and treatment of frailty, resulting in better care and 
healthier aging for older people.
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Introduction
Life expectancy has markedly increased worldwide during the past 100 years, mainly 
due to public health improvements.1 This demographic transformation of the popula-
tion has resulted in growing numbers of older adults in both developing and developed 
countries.2 Between 2000 and 2050, the proportion of people aged 60 years or older 
in the world is projected to double from about 11% to 22%, an increase from 605 
million to 2 billion adults aged ≥60 years.1 The number of older adults aged over 80 
years is expected to quadruple to 395 million during the same period.1 In general, we 
tend to develop more health problems and become frailer as we age. The increase in 
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life expectancy allows chronic diseases to develop while 
physical and cognitive functions decline, which predisposes 
older people to disability or dependency.
Older adults are a highly heterogeneous group. Their life 
courses of health and functional status vary substantially, 
depending on their genetic, biological, and environmental 
backgrounds as well as other physical, psychological, and 
social factors. Therefore, individuals with the same chrono-
logical age can have different biological ages.3 Frailty has 
received increasing scientific attention as a way of under-
standing health diversity among older adults.4 In the past, 
the term frailty was used almost interchangeably with aging, 
disability, or comorbidity, partly because of the similarity and 
high coexistence rate of these descriptive states.5 However, 
there are clear differences between frailty, aging, disability, 
and comorbidity. First, advanced age on its own does not 
necessarily mean vulnerability to negative health outcomes 
so typical of frailty.6 Frailty is at least partly programmed in 
early life and is also associated with lower socio-economic 
status in adulthood.7 Second, frailty is conceptualized as a 
state of decreased physiological reserve and compromised 
capacity to maintain homeostasis as a consequence of age-
related, multiple, accumulated deficits.4 Frail older people 
are highly vulnerable to adverse health outcomes when 
exposed to an internal or external stressor.4 Third, whereas 
frailty refers to instability and risk of loss of function, dis-
ability indicates loss of function and often assessed based 
on difficulty or dependency in performing activities neces-
sary to live independently, such as activities of daily living 
(ADL), eg, bathing, dressing, eating, toileting, continence, 
and transferring8 and instrumental activities of daily living 
(IADL), eg, shopping, telephone use, meal preparation, 
housekeeping, laundry, transportation, medication, and 
finances.9 Finally, comorbidity is defined as having two or 
more medically diagnosed diseases.5 Thus, frailty is clearly 
different and distinguishable from advanced age, disability, 
and comorbidity.
Definition of frailty
A number of definitions have been proposed to conceptualize 
and operationalize frailty.10,11 Despite the long-lasting and 
extensive debates on how best to define frailty, international 
consensus has yet to be reached and a gold standard definition 
of frailty is still lacking.4 Nonetheless, most conceptual frailty 
definitions have some factors in common, such as decreased 
reserves/capacity to tolerate minor stressors, increased 
vulnerability to adverse health outcomes, and impairment 
in multiple physiological systems.10 After the inclusion of 
these factors, frailty is conceptually defined as “a clinically 
recognizable state in which the ability of older people to 
cope with everyday or acute stressors is compromised by an 
increased vulnerability brought by age-associated declines 
in physiological reserve and function across multiple organ 
systems”.12 This definition by the WHO has been widely 
accepted4,13 and adopted in the Joint Action ADVANTAGE, 
a recently launched European Union (EU) initiative.14
Among various frailty definitions, the most commonly 
used is the frailty phenotype,15 developed by Fried et al 
using the Cardiovascular Health Study cohort in 2001.16 The 
Fried frailty phenotype consists of five physical components 
to define frailty: unintentional weight loss, self-reported 
exhaustion, weakness, slow walking speed, and low physical 
activity.16 Individuals are considered to be frail when they 
meet three or more criteria, and they are considered to be 
robust when they have none.16 Individuals who have one or 
two criteria are defined as prefrail, a state between robust 
and frail.16
The Frailty Index is another popular approach,15 based 
on a cumulative deficit model advocated by Mitnitski et al 
using the Canadian Study on Health and Aging.17 In contrast 
to the frailty phenotype, this cumulative deficit approach 
describes frailty as a state caused by the accumulation of 
health deficits during the life course, and the more deficits 
individuals have, the more likely they are to be frail.15 The 
Frailty Index, a continuous score ranging from 0 (no deficit) 
to 1 (all deficits present), is calculated as the ratio of the 
number of deficits present in the individual to the number 
of total deficits considered.18 For the Frailty Index, at least 
30–40 deficits, associated with age and adverse health out-
comes that are prevalent in 1% or more of the population, 
should be considered, with fewer than 5% of missing values, 
and it can include symptoms, signs, diseases, disabilities, 
abnormalities of laboratory, radiographic, and electrocar-
diographic findings, and social characteristics.18
There has been some debate regarding the practical appli-
cation of these two most commonly used frailty definitions.19 
The frailty phenotype requires special equipment to measure 
the handgrip strength and space for measuring gait speed. The 
population-based lowest 20% of the handgrip strength, gait 
speed, and physical activity need to be calculated based on 
the population distributions. Calculation of the Frailty Index 
requires the recording of various types of deficits (typically 
more than 30–40) and dividing the number of deficits present 
by the number of deficits considered, which may take ~20–30 
minutes,19 except when data are extracted and calculated 
automatically from electronic medical records.20





Feasible frailty instruments in a clinical 
setting
According to the International Association of Nutrition and 
Aging (IANA) Task Force, a frailty tool should be quick, inex-
pensive, reliable, and easy to use in clinical settings because 
the identification of frail older people at risk is an important 
initial step potentially leading to appropriate preventive and/
or treatment interventions and ultimately to higher quality 
care for this vulnerable population.21 From this perspective, 
the frailty phenotype and the Frailty Index may be rather 
impractical and unfeasible especially in a busy clinical set-
ting. Based on a systematic review of the literature as well 
as input from a panel of geriatric experts, the IANA’s work-
ing group advocated a new frailty tool.21 The FRAIL scale 
is a simple tool consisting of five yes/no questions: Fatigue, 
Resistance (inability to climb stairs), Ambulation (inability to 
walk a certain distance), Illnesses (more than five of comor-
bidities), and Loss of weight (more than 5%),21 and has been 
shown to be able to predict mortality and incident ADL and 
IADL disabilities among community-dwelling older people 
in recent meta-analysis studies.22,23 The FRAIL scale is also 
recommended as one of the tools to detect frailty by the Joint 
Action ADVANTAGE, a EU co-funded initiative launched in 
2017 involving 22 member states and over 40 organizations.14 
The main goal of ADVANTAGE is to establish a common 
European framework for addressing the problems of frailty, 
including: 1) improvements in screening, diagnosis, preven-
tion, and treatment for frailty, 2) health care system reforms 
adapted to population aging, and 3) facilitation of research 
and education on frailty.14 ADVANTAGE has proposed that 
tools used for frailty screening should be quick to admin-
istrate (no more than 10 minutes to complete); require no 
special equipment; validated; and be meant for screening. 
Existing frailty instruments meeting these four criteria are 
Clinical Frailty Scale, Edmonton Frail Scale, FRAIL scale, 
INTER-FRAIL, Prisma-7, Sherbrooke Postal Questionnaire, 
Short Physical Performance Battery, and Study of Osteopo-
rotic Fractures Index.14 The Kihon Checklist, a self-reported 
comprehensive questionnaire consisting of 25 simple yes/no 
questions covering multiple domains, is another relatively 
new frailty tool.24,25 This tool was originally developed by 
the Japanese Ministry of Health, Labour and Welfare in 
2005–2006 as a screening tool to identify vulnerable older 
adults who are at high risk of dependency and more recently 
has been recognized as a useful frailty assessment tool.26,27 
This is another brief, simple, quick, and cost-effective instru-
ment which does not need special equipment and takes <10 
minutes to complete,19 and therefore may be appropriate for 
screening. These frailty instruments can easily be incorpo-
rated into comprehensive geriatric assessment or primary 
care in a clinical setting for screening frail older adults. Some 
of them consist of short lists of simple questions and can 
be administered by not only physicians or other health care 
professionals but also care givers and non-professionals, in 
person as well as by phone, mail, or email.
Prevalence and natural course of 
frailty
The mean prevalence of frailty among the community-
dwelling population aged 65 years and older is ~10% but 
can range widely from 4.0% to 59.1% depending on the 
frailty criteria used.28 Advanced age is a significant risk fac-
tor for frailty and a quarter of those aged 80 years or older 
are frail.28 A higher prevalence of frailty is also observed in 
selected populations with specific diseases or conditions, 
such as patients with cancer (42%),29 end-stage renal disease 
(37%),30 heart failure (45%),31 Alzheimer disease (32%),32 
and nursing home residents (52%).33
Although the mean prevalence of frailty gradually 
increases with age,28,34–37 the individual course of frailty 
varies and the level of frailty can be reduced even in old 
age.4,38 Several longitudinal population-based studies have 
showed that 8.3%–17.9% of older adults actually improved 
their frailty status39–44 and that some of them made frequent 
and dynamic transitions over time.45
Impacts of frailty on health care 
systems
Frail older adults are at increased risk of premature 
death20,22,27,46 and various negative health outcomes, including 
falls,47 fractures,48 disability,23,49 and dementia,50 all of which 
could result in poor quality of life51 and increased cost52 and 
use of health care resources,53 such as emergency department 
visits,54 hospitalization,55 and institutionalization.56 Multiple 
studies using cohorts of community-dwelling older adults 
have showed that the health care costs of frail individuals 
are sometimes several-fold higher than those of non-frail 
counterparts.57–61
Older adults form the main users of medical and social 
care services,62 and the majority of health care costs are 
incurred by them. In the context of ongoing population aging, 
with an unprecedented growing number and proportion of 
older adults, this epidemiological and demographic popula-
tion shift is starting to have a major impact on health care 
systems. Current health care systems are mostly designed to 
address organ-specific and disease-specific problems one at 





a time and are not well prepared to deal with the chronic and 
complex medical needs of frail older patients and to provide 
seamless care for them in the long term.63,64 Therefore, older 
patients often receive suboptimal care due to the fragmented 
delivery of appropriate treatments and services.65
Interventions for frailty
There is no standard treatment of choice specifically for 
frailty, but there is a need for high quality cost-effective 
health care strategies to counter frailty.66 Although various 
types of frailty intervention models have been developed and 
investigated, there is a considerable degree of heterogeneity 
in terms of optimal intervention type, sample size, population 
characteristic, setting, baseline frailty status, frailty defini-
tion, and outcomes, and most findings are inconclusive.67–74 
At present, it is therefore not possible to conclude what 
intervention is the most effective and appropriate. Overall, 
multi-domain intervention trials, which have been frequently 
conducted,75,76 and many of which included an exercise com-
ponent, seemed to have some favorable effects (although not 
in all trials) compared with mono-domain interventions or the 
control.73,77 Among the various outcome measures, functional 
ability, disability, and falls have been commonly examined 
while only a limited number of trials investigated changes 
in frailty status as an outcome.78 Although it is still not clear 
which frailty intervention is the most effective, exercise 
programs, especially multicomponent exercise including 
resistance training, have been consistently successful and 
seem likely to play a pivotal role in frailty interventions.79–84
Implications and challenges for 
health care policy
One of the plausible implementations of frailty into clinical 
practice is to identify frail patients using electronic health 
record data.85–87 In a UK study, Clegg et al developed the 
electronic Frailty Index (eFI) from 36 deficits,88 based on 
the Frailty Index of cumulative deficit model.17 The eFI was 
automatically populated from routinely collected data stored 
in the existing primary care electronic health record where 
general practitioners (GPs) list all patient diagnoses.88 The 
authors showed eFI was able to stratify patients according 
to the degree of frailty and had robust predictive validity for 
mortality, hospitalization, and nursing home admission.88 
In 2017, NHS England started to require GPs to identify 
patients aged 65 years or older with moderate and severe 
frailty using validated frailty instruments including eFI, 
which is now freely available at most of GP practices.89 
Following clinical assessment, patients with severe frailty 
are monitored using an annual medication review and other 
clinically relevant interventions if appropriate.89 This is 
probably the first attempt of nation-wide population-based 
frailty risk stratification and health utilization predictions in 
health care systems.90
Population-based screening for frailty could be expensive 
and resource intensive, and currently there is no clear evi-
dence for potential benefit, cost-effectiveness, or improved 
outcomes.91 Nonetheless, at the Frailty Consensus Conference 
in 2012, it was concluded that screening for frailty should be 
recommended for people with specific conditions or in certain 
settings.92 One of the four consensus points was that those 
aged 70 years or older and those with significant weight loss 
(≥5%) due to chronic disease should be screened for frailty.92 
This recommendation is supported by the ADVANTAGE 
initiative, which advocates opportunistic frailty screening 
of people aged over 70 years receiving health care at any 
level of the system.14 The French Society of Geriatrics and 
Gerontology suggests that people aged over 75 years who 
do not have difficulty with simple ADL but with early IADL 
would be good candidates for screening.93 The UK practice 
guidelines for frailty published from the British Geriatrics 
Society, Age UK, and Royal College of General Practitioners 
in 2014 recommend conducting a frailty assessment using all 
the encounters between health and social care staff and older 
people in community and outpatient settings.94 Research and 
development efforts aimed at establishing and disseminating 
best practice in frailty should not lack policy attention to older 
people with early (pre-) frailty that misses an opportunity to 
address some demands on health and social care services.95
Among the current challenges in the field of frailty 
research, one of the most important issues is the lack of an 
international standard definition of frailty.92,96 Despite accu-
mulated research evidence on frailty, the variability in frailty 
definitions used in existing studies influences interpretation of 
the evidence, comparison with other studies, generalization 
of findings, and its implementation in the health care policy. 
In order to further advance and improve the health care 
services for frail older adults, it is imperative to come to an 
agreement in terms of frailty definition.97 Ideally, the defini-
tion should be not only reliable but also feasible and easy to 
apply.98 Based on the currently available evidence on frailty 
intervention, there is strong evidence that exercise is central 
and possibly the optimal treatment of frailty. This needs to 
be explored further through multi-domain interventions that 
include exercise. The best timing for frailty intervention is 
not known but could range from intervening proactively to 
decrease risk of developing frailty or targeting those who are 





found to be prefrail or frail at the time of screening. If these 
concerns are properly addressed, widespread application of 
public health approaches will be possible, including screen-
ing, identification, and treatment of frailty, resulting in better 
care and healthier aging for older people. Involving frail 
older people in exploration of responses to frailty is likely to 
be fruitful; a Swedish study showed that financial situation, 
self-rated health, and social networks were determinants of 
life satisfaction. Actions that benefit life satisfaction – social 
and financial support – should be promoted.99
Another important area of frailty research is education 
and training. In order to deliver high quality care and services 
effectively and efficiently to frail older adults, health care 
professionals including physicians, nurses, and other medi-
cal workers need to understand basic principles of care for 
frail older adults and to be able to detect frailty and provide 
treatment/interventions. Different understandings of frailty 
may impede communication between disciplines and need 
to be addressed. However, the evidence on education or 
training for frailty management is lacking. A recent system-
atic review that involved searches until May 2017 found no 
relevant article on education and/or training interventions 
for health care professionals in the field of frailty.100 There 
are currently ongoing frailty projects including educational 
components targeting health care professionals, patients, and 
caregivers, and new findings from these projects are expected 
to contribute to the field of frailty.14,100
There is an increasing interest in frailty in other medical 
fields than the geriatrics.101,102 One example is that frailty has 
recently been pursued as a potential risk assessment measure 
for older surgical patients and has shown to be promising in 
predicting post-operative complications, such as mortality 
or length of hospital stay.103 However, the lack of knowledge 
about frailty is a major barrier to the preoperative frailty 
assessment by surgeons, which may be addressed by educa-
tion and training.104 A US educational interventional study 
involving cardiothoracic surgery residents showed that online 
short courses on frailty significantly improved residents’ 
knowledge of frailty and influenced surgical risk estimates.105
Finally, frailty research may have evolved without taking 
into account the patient perspective. Frailty can be considered 
as a highly negative term and being labeled as frail may affect 
negatively the most vulnerable individuals in various ways. 
Those who were labeled as “old and frail” by others were 
more likely to be associated with a loss of interest in social 
and physical activities, poor physical health, and increased 
stigmatization.106 The future research and development efforts 
need to acknowledge the risks of labeling older people in 
stigmatizing ways, and avoid frailty from becoming the new 
cloak of ageism and a tool for discrimination.107
Conclusion
There is an urgent need to identify and implement effec-
tive long-term care schemes to meet the complex demands 
of older adults. Frailty is potentially a perfect fit as a risk 
stratification paradigm and has therefore been recognized 
as an emerging public health priority.13Although a growing 
number of frailty studies have been conducted over the last 
two decades, their findings have not yet been fully translated 
into clinical practice108 and the implementation of evidence 
on frailty in health care policy-making is further underrep-
resented.95 Successful implementation has the potential to 
improve quality of care for frail older adults and promote 
healthy aging as well as diminish the impact of frailty on 
health care systems and strengthen their sustainability. 
Such actions further demonstrate the substantial public 
health importance of frailty. Given the multidimensional 
and heterogeneous nature of frailty and the complex care 
needs of frail older adults, a multidisciplinary collaborative 
approach is needed between researchers, clinicians, policy 
makers, and older people themselves to improve the health 
and well-being of this subgroup of older adults.109,110 The 
field of frailty is still evolving and expanding and will need 
much more time and effort for further progress to occur.96 
Better outcomes for older people are likely to come with 
a time lag, and addressing frailty may require a massive 
cultural (perhaps generational) shift in the organization of 
health and care systems.90
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